Biomarin Pharmaceutical Inc. (BMRN)

Index:

Nasdaq 100

$ 60.26
   
  • Change Today:
    $-1.09
  • 52 Week High: $69.72
  • 52 Week Low: $49.64
  • Currency: US Dollars
  • Shares Issued: 179.84m
  • Volume: 1,791,426
  • Market Cap: $10,837m
  • RiskGrade: 181
  • Beta: 0.01

Latest ShareCast News

BioMarin buys pharma peer Amicus for $4.8bn

By Benjamin Chiou

Date: Friday 19 Dec 2025

(Sharecast News) - Shares in BioMarin surged on Wall Street on Friday after the pharma group agreed to buy smaller peer Amicus Therapeutics for $4.8bn, expanding its position in the rare diseases market.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BMRN Market Data

Currency US Dollars
Share Price $ 60.26
Change Today $ -1.09
% Change -1.78 %
52 Week High $69.72
52 Week Low $49.64
Volume 1,791,426
Shares Issued 179.84m
Market Cap $10,837m
Beta 0.01
RiskGrade 181

What The Brokers Say

Strong Buy 9
Buy 9
Neutral 5
Sell 1
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Sep-2026

Time Volume / Share Price
15:59 114 @ $60.24
15:59 825 @ $60.26
15:59 279 @ $60.25
15:59 400 @ $60.25
15:59 100 @ $60.25

Top of Page